Toggle navigation
Browse
Home
Researchers
Research Departments
Publications
About/Support
Zanidatamab for HER2-amplified, unresectable, locally advanced or metastatic biliary tract cancer (HERIZON-BTC-01): a multicentre, single-arm, phase 2b study
Article
Hot Paper
International Collaboration
Overview
Research
Additional Document Info
View All
Overview
cited authors
Harding, James J.; Fan, Jia; Oh, Do-Youn; Choi, Hye Jin; Kim, Jin Won; Chang, Heung-Moon; Bao, Lequn; Sun, Hui-Chuan; Macarulla, Teresa; Xie, Feng; Metges, Jean-Phillippe; Ying, Jie'er; Bridgewater, John; Lee, Myung-Ah; Tejani, Mohamedtaki A.; Chen, Emerson Y.; Kim, Dong Uk; Wasan, Harpreet; Ducreux, Michel; Bao, Yuanyuan; Boyken, Lisa; Ma, Jiafang; Garfin, Phillip; Pant, Shubham; HERIZON BTC 01 Study Grp
Publication Date
July 1, 2023
webpage
Web of Science
published in
LANCET ONCOLOGY
Journal
Research
category
ONCOLOGY
Web of Science Category
Additional Document Info
start page
772
end page
782
volume
24
issue
7